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Downregulation of MHC class I molecules is a strategy developed by some viruses to escape cellular immune responses. Myxoma virus
(MV), a poxvirus causing rabbit myxomatosis, encodes MV-LAP that is known to increase MHC-I endocytosis and degradation through a
C4HC3 motif critical for an E3 ubiquitin ligase activity. Here, we performed a functional mapping of MV-LAP and showed that not only the
C4HC3 motif is necessary for a marked downregulation of MHC-I but also a conserved region in the C-terminal part of the protein. We also
showed that the putative transmembrane domains are responsible for a specific subcellular localization of the protein: they retain MV-LAP in
the ER in transfected cells and in the endolysosomal compartments in infected cells. We observed that a specific MV infection context is
necessary for a fully efficient downregulation of MHC-I. Our data suggest that the functionality of viral LAP factors, inherited by herpes- and
poxviruses from mammalian cells, is more complex than anticipated.
D 2005 Elsevier Inc. All rights reserved.Keywords: Poxviruses; Myxomatosis; Myxoma virus; MHC-I; Regulation; Cell surface receptors; Virulence; Viral proteins; UbiquitinIntroduction
DNA viruses take advantage of their large genomes to
encode many factors that subvert the immune response.
Downregulation of cellular membrane glycoproteins is one
of the many strategies developed by viruses to disturb
cellular trafficking and to escape from the host immune
response. One of the most critical actions is the down-
regulation of MHC class I molecules from the cell surface
which is associated with the diminution or abrogation of
CTL activity and allows viruses to persist and replicate more
easily in the host. Adenovirus E19 glycoprotein (Bennett0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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. Deceased 29 August 2005.et al., 1999), US2, US6 and US11 proteins of human
cytomegalovirus (Ahn et al., 1997; Hengel et al., 1997;
Lehner et al., 1997; Wiertz et al., 1996) and m06 protein of
mouse cytomegalovirus (Reusch et al., 1999) are examples
of factors responsible for such an MHC-I downregulation.
Recently, a new family of herpes- and poxviral factors
involved in the downregulation of immune markers (such as
MHC class I) was identified: MK3 of mouse herpesvirus 68
(Stevenson et al., 2000); Mir1 and Mir2 (or K3 and K5,
respectively) of human herpesvirus 8 (Coscoy and Ganem,
2000; Ishido et al., 2000a); and MV-LAP (m153R protein)
of myxoma virus (MV) (Guerin et al., 2002) share a
conserved primary structure with a C4HC3 motif in the N-
terminus of the protein and two putative transmembrane
domains. In our previous work, the name scrapins was
proposed to designate these surface cell receptor abductor
proteins (Guerin et al., 2002). Other authors refer to these05) 171 – 178
Fig. 1. Structure of MV-LAP and identification of a C-terminal conserved
region. (A) General structure of MV-LAP. TM, transmembrane domain;
CR, conserved region. Numbers above the diagrams, positions of amino
acids flanking the motifs. (B) Sequence alignments of the newly defined
CR of viral Scrapins. HHV8, human herpesvirus 8; SFV, Shope fibroma
virus; YLDV, Yaba like disease virus; SPV, swinepox virus; LSDV, lumpy
skin disease virus. Shadowed letters, identical amino acids (factor of 0.45);
light gray letters, related amino acids. Boxed letters are CR region
previously described in herpesviral Mir-1 and Mir-2 proteins (Sanchez et
al., 2002). Stars represent four critical clusters (Clr1-4) for Mir1 function
(Means et al., 2002).
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(Coscoy et al., 2001) or K3 (Fruh et al., 2002) family.
Some members of this family have recently been
described to be able to promote the ubiquitination of the
cytoplasmic tail of their targets. This phenotype is attributed
to an E3 ligase activity, critically related to the presence of a
functional C4HC3 domain (Boname and Stevenson, 2001;
Coscoy et al., 2001; Mansouri et al., 2003). Ubiquitination
promoted by the ER-localized MK3 protein of MHV-8 leads
to the degradation of MHC-I by the proteasome (Boname
and Stevenson, 2001). Interestingly, althoughMir1 andMir2
of HHV8 are also ER residents (Coscoy and Ganem, 2000;
Haque et al., 2001; Ishido et al., 2000a), ubiquitination of
their targets (MHC-I, B7.2, ICAM-1 for Mir2, MHC-I for
Mir1) is associated with degradation in the endolysosomic
pathway after enhanced endocytosis (Coscoy and Ganem,
2000; Ishido et al., 2000b). This highlights the fact that at
least two distinct mechanisms are used by herpesviral scrap-
ins to interfere with the surface expression of cellular proteins.
Among poxviruses, only MV-LAP (m153R protein) of
MV has been characterized so far: This scrapin, previously
described to be localized in the ER, downregulates MHC-I,
CD95 (Guerin et al., 2002) and CD4 (Mansouri et al., 2003)
molecules. It was demonstrated that MV-LAP possesses an
E3 ubiquitin ligase activity, like its herpesviral counterparts
(Mansouri et al., 2003). However,many aspects of the intimate
relationship between localization and function of the protein
remain unclear. Moreover, it is not known whether poxviral
scrapins and their herpesviral homologs share the same
molecular mechanisms to downregulate surface molecules.
In order to investigate MV-LAP functionality and
determine how closely related are herpes- and poxviral
scrapins, we decided to perform a molecular mapping of the
protein. In this study we demonstrate that MV-LAP shares all
the structural characteristics of herpesviral immune modu-
lators; however, it requires a particular context to be fully
functional: This is the first member of the scrapins (or MIR
family) described to require the help of a specific viral
partner to optimize the downregulation of MHC-I molecules.Results
Identification of a conserved region (CR) within MV-LAP
M153R codes for the 206 amino acids (aa) MV-LAP
protein which contains a C4HC3 domain between aa 23 and
68 and two putative transmembrane domains between aa 95
and 115 and aa 135–153 (Fig. 1A). A previous study
performed on herpesviral scrapins Mir1 and Mir2 of HHV8
showed the existence of a conserved region (designated CR)
in the C-terminal domain (Fig. 1B, boxed region) (Sanchez
et al., 2002). An independent analysis revealed four critical
clusters for Mir1 activity: three belong to the CR and one
lies downstream (Fig. 1B, clusters represented by stars)
(Means et al., 2002).In order to assess if such a domain is present in the
poxviral scrapin, we performed a bioinformatic analysis of
MV-LAP. As shown in Fig. 1, we found a relatively
conserved CR domain adjacent to the second transmem-
brane domain of MV-LAP, reminiscent of the CR of Mir1
and Mir2. We decided to enlarge the CR including the
subsequent 13 aa in order to integrate the fourth cluster of
Mir1 (which is an acidic cluster).
A context of infection is critical for MHC-I downregulation
by MV-LAP
Our next step was to determine the role of each domain
in the function of MV-LAP. A previous work indicated a
dramatic decrease of MHC-I molecules at the surface of
BGMK or Malme 3 M cells infected with wild-type MV
(Guerin et al., 2002). Surprisingly, our first attempts using
A375 cells (and other cell types) transfected with pEGFP-
MVLAP showed that MHC-I molecules were downregu-
lated only weakly, far below the level obtained in infection
experiments (Figs. 2b and c). Several hypotheses were
formulated to explain this discrepancy, e.g., the potential
need for a minimum strength of expression or the influence
of GFP protein co-production. First, we decided to
construct a pmyxGFP-MVLAP plasmid, in which the
promoter region of MV-LAP replaced the CMV promoter
Fig. 2. A context of infection is critical for MHC class I downregulation by MV-LAP. A375 cells were either mock infected (a), infected with wild-type MV (b),
transfected by pEGFP-MVLAP (c), transfected by pEGFP-MVLAP and infected with MV-DLAP (d). As a control, cells were also transfected with pEGFP in
the absence (e) or presence (f) of MV-DLAP infection. MHC-I class I surface expression was then measured using HLA A2.1 antibodies. Displayed events:
10,000 cells/dot plot.
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poxviral transcription machinery, we realized a trans-
fection/infection assay with pmyxGFP-MVLAP and MV-
DLAP. MV-DLAP is derived from the wild-type MV by
deletion of the MV-LAP open reading frame (Guerin et al.,
2002). Only the cells that were both transfected and
infected could express MV-LAP (and GFP): in those cells,
the downregulation was restored to the level observed inTable 1
Functional mapping of MV-LAP
Mutants of MV-LAP lacking PHD/LAP, or partially or fully CR region were clone
transfection of A375 cells infected with an MV-DLAP virus (MOI = 10), MHC clas
protein was determined by confocal microscopy. The truncations were stably exp
shown).infection (data not shown). Interestingly, infection with
MV-DLAP of A375 cells transfected with pEGFP-MVLAP
gave similar results (Fig. 2d). These data indicate that
neither the presence of GFP in the N-terminus of the
protein nor the promoter driving MV-LAP expression
influences the activity of the scrapin. Rather, a context of
viral infection seems crucial for complete functional
activity.d in pEGFP vector in order to generate GFP fusion proteins. After transient
s I surface expression was measured. Subcellular localization of each fusion
ressed, as judged by immunofluorescence analysis and flow cytometry (not
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Since the more dramatic effects are obtained in trans-
fection/infection experiments, we decided to perform the
functional mapping of MV-LAP by complementing pEGFP-
MVLAP-derived plasmids with MV-DLAP virus. In order
to investigate the role of the LAP, TM and the newly
identified CR domains in the downregulation of MHC-I
molecules, we constructed a series of plasmids with the gene
coding for GFP fused to various deletions of MV-LAP
(Table 1). The full-length MV-LAP generates significant
downregulation of MHC-I molecules, whereas each of the
mutants we tested had no effect, suggesting that every
domain of the scrapin is critically required for its function.
In parallel, we observed the subcellular localization of the
GFP-tagged proteins and determined that in the absence of
the TM domains the proteins were diffusely distributed in
the cell (similar to GFP alone, data not shown). The
presence of the TM domains restored the targeting of MV-
LAP constructs to punctuated substructures (Table 1).
Hence, the TM domains are necessary for the specific
localization of MV-LAP, where the C4HC3 and CR are both
essential for downregulating MHC-I molecules. These
results are reminiscent of those observed with the herpes-
viral Mir2 protein (Sanchez et al., 2002), demonstrating that
the poxviral and herpesviral scrapins share very similar
molecular characteristics.
A MV cofactor is required for MHC-I downregulation by
MV-LAP
To understand why infection was favorable to a proper
downregulation of MHC-I molecules in A375 cells, we
compared the effects of MV with modified vaccinia virus
Ankara (MVA), an Orthopoxvirus which does not code for
an equivalent of MV-LAP (Antoine et al., 1998). A MVA-Fig. 3. A myxoma cofactor is necessary to achieve maximal downregulation
of MHC class I molecules by MV-LAP. A375 cells were mock infected,
infected with MV, MV-DLAP, MVA-GFP-MVLAP or both MVA-GFP-
MVLAP and MV-DLAP. 15 h post-infection, cells were treated with HLA
A2.1. antibodies and analyzed by FACS (gated for GFP).GFP-MVLAP recombinant virus expressing a fluorescent
MV-LAP protein through transcriptional control of the
vaccinia virus early/late P7.5 promoter was used in
infection assays of A375 cells. Fifteen hours post-infected,
we quantified the MHC-I molecules at the cell surface and
found that when MV-LAP was expressed by MVA the
downregulation was very weak, in comparison with
infection with the wild-type MV (Fig. 3). Alternatively,
we complemented MVA-GFP-MVLAP-infected A375 cells
with MV-DLAP. Now, cells that were co-infected dis-
played a dramatic decrease of MHC-I molecules at their
surface, comparable to that observed in wild-type MV-
infected ells (Fig. 3). This surprising result suggests that
one or several factors specific of MV are required.
As a control, we also tried to complement transfected
pmyxGFP-MVLAP plasmid with a wild-type MVA infec-
tion. Indeed, MVA is able to activate the early promoter of
MV-LAP. However, MVA could not complement the effect
of MV-LAP and MHC-I levels remained as poorly modified
as in transfection experiments only (data not shown). Our
results demonstrate that a factor expressed by MV, but not
MVA, is necessary for the activity of MV-LAP.
MV-LAP cofactor does not influence its subcellular
localization
Since our previous data had shown that the intracellular
localization can determine the function of MV-LAP, we
explored the possibility that MV – but not MVA – could
properly redirect the scrapin in the cell. To address this
question, we determined the localization of GFP-tagged
MV-LAP expressed in various experimental conditions.
When pEGFP-MVLAP was transfected in A375 cells, the
green fluorescence colocalized with calnexin, indicating that
the viral protein was in the endoplasmic reticulum (Fig. 4).
When the transfection experiment was complemented by
transfection with MV-DLAP, the green fluorescence was
localized in the late endosomal compartment, revealed by
EEA-1 staining (Fig. 4). In another assay, we observed that
MVA-GFP-MVLAP also directed the scrapin to endosomes.
Coinfecting A375 cells with MVA-GFP-MVLAP and MV-
DLAP did not change its distribution. These observations
suggest that the endosomal localization of the protein is a
consequence of the infected status of the cell, whether the
infection results from MV or MVA.Discussion
A conserved family of viral proteins is used by
poxviruses and herpesviruses to downregulate surface
molecules of immune cells (for a review, see Fruh et al.,
2002). While MIR or scrapin proteins of herpesviruses are
being extensively studied, little is known about their
counterparts in poxviruses. Indeed, like herpesviral pro-
teins, MV-LAP is expressed early in the viral cycle,
Fig. 4. Subcellular localization of GFP-MV-LAP. A375 cells were transfected with pEGFP-MVLAP (A, B) or infected with MVA-GFP-MVLAP (C, D) in the
absence (A, C) or presence (B, D) of MV-DLAP. 15 h post-infection, cells were treated with anti-calnexin or anti-EEA1 antibodies and analyzed by confocal
microscopy.
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MHC-I molecules by enhancing their endocytosis (Bosh-
kov et al., 1992; Guerin et al., 2002; Mansouri et al.,
2003). Among the structural features shared by the two
families of viruses are the presence of a C4HC3 domain
which possesses a ubiquitin ligase activity (Coscoy and
Ganem, 2003; Mansouri et al., 2003) and two transmem-
brane (TM) domains (Guerin et al., 2002). The TM domains
of Mir2 are responsible for the oligomerized status of the
protein as well as target selection (Sanchez et al., 2002).
Mir1 and Mir2 also possess a critical region with conserved
motifs downstream of the TM domains (Means et al., 2002;
Sanchez et al., 2002). This conserved region (CR) has a
tyrosine-based motif adjacent to conserved residues, fol-lowed by a proline-rich motif and two diacidic clusters. We
performed an alignment between MV-LAP, other scrapins of
poxviruses and Mir1 and Mir2 of HHV-8, and showed that
poxviruses also have conserved residues at the C-end of the
protein. This newly defined CR of poxviruses based on
sequence similarities has conserved some key residues, and
acidic clusters are present. The CR of Mir1 and Mir2 are
required for MHC-I downregulation (Means et al., 2002;
Sanchez et al., 2002): the tyrosine-sorting motif and the
conserved residues direct the MHC-I molecules to the TGN,
where they are retargeted to the lysosomal compartment via
the diacidic regions (Means et al., 2002). Detailed mecha-
nism remains speculative. Our analysis of deletion mutants
supports the notion that MV-LAP is composed of multiple
N. Collin et al. / Virology 343 (2005) 171–178176domains, including a CR, each of which is required to
achieve efficient downregulation of MHC-I molecules.
While the C4HC3 domain is a ubiquitin ligase that transfers
ubiquitin groups to the cytosolic tail of target molecules
(Mansouri et al., 2003), the TM domains are necessary for a
proper subcellular localization of the protein.
This rises a very intriguing aspect of scrapin function-
ality, which enhances the internalization of molecules
exposed to the plasma membrane, while residing in the
ER (Coscoy and Ganem, 2000; Haque et al., 2001; Ishido et
al., 2000a). How this is achieved is debated, and some
authors suggest that a small proportion of Mir2 escapes the
ER compartment to the plasma membrane (Sanchez et al.,
2002). While previous experiments with GFP-tagged
proteins expressed by a plasmid had indicated that MV-
LAP resides in the ER (Guerin et al., 2002), others observed
that the protein is localized in the endosomal and TGN
compartments when expressed by a vaccinia virus vector
(Mansouri et al., 2003). We constructed an MVA-GFPLAP
recombinant virus, which expresses MV-LAP under the
control of the early/late P7.5 promoter. This helped confirm
the observation that MV-LAP localizes to the ER when
expressed in transfected cells but to endosomes when
expressed by a poxviral vector. MV-LAP, when expressed
by a plasmid, also localizes to endosomes in cells infected
with a recombinant MV-DLAP virus. Hence, either some
viral protein tethers MV-LAP and drives it from the ER to
endosomes, or poxviral infection remodels cell architecture
and trafficking so that MV-LAP localizes in endosomes.
Without anticipating on the mechanisms, one can safely
assume that the biological compartment of MV-LAP is the
endosomes/TGN rather than the ER. Since localization
experiments of herpesviral proteins were interpreted in a
context of transfection, it would be informative to reproduce
them after complementation with herpes infection.
While both MVA and MV target MV-LAP to endosomes,
the biological effects of MV-LAP are not equivalent in both
contexts: In A375 cells the downregulation of MHC-I was far
more dramatic when cells were infected with MV than with
MVA expressing MV-LAP. MVA does not replicate in A375
cells but can still express both early and late genes (data not
shown). Hence, it is very unlikely that the difference between
MVA and MV-DLAP can be attributed to different levels of
expression of the same gene products made by both viruses.
Obviously, one or more proteins specific of MV infection
act as cofactors to ensure maximal activity of MV-LAP.
Our hypothesis of the existence of a cofactor is strength-
ened by previous observations: Although MV-LAP is
expressed as an early gene product (Guerin et al., 2002)
MHC-I downregulation is only moderate in the presence of
Ara C, an inhibitor of DNA replication hence of late gene
expression (Boshkov et al., 1992). More recently, it was
shown that redistribution of MHC-I molecules from the ER is
influenced by the addition of Ara C, although this drug does
not affect their accumulation and degradation in late endo-
somes (Zuniga et al., 1999). These data suggest the require-ment for one or more intermediate and/or late gene products
to achieve maximal effect. This additional factor alone is
unable to affect MHC-I surface expression, since a recombi-
nant MV-DLAP virus has no effect on the level of MHC-I
molecules (Guerin et al., 2002; Mansouri et al., 2003).
Structural and functional homologs of poxvirus and
herpesvirus modulators of immune recognition have been
discovered in mammalian genomes where they are desig-
nated as MARCH (membrane-associated RING-CH) pro-
teins (Bartee et al., 2004). MARCH proteins regulate
endocytosis of various cell surface receptors via ubiquiti-
nation. All the information that can be obtained on the
function of Mir/Scrapin proteins will be valuable for a
deeper knowledge of how MARCH function. Since MV can
be easily grown on a wide variety of cell line as well as it
infects the European rabbit with a dramatic clinical out-
come, such information might be easier to obtain in a
poxviral than a herpesviral model system.Materials and methods
Cells, viruses, transfections and infections
The wild-type strain T1 and the MV-DLAP mutant virus
of MV were grown in the rabbit kidney cell line RK13
maintained in OPTI minimum essential medium supple-
mented with 2% fetal calf serum. The MV-DLAP mutant is
derived from T1 after deletion of theMV-LAP gene (m153R)
by insertion of a lacZ cassette (Guerin et al., 2002). Human
skin melanoma A375 human cells (ATCC CRL-1619) were
maintained in RPMI medium with 10% calf serum and 25
mM HEPES. Subconfluent layers of A375 cells were
transfected with plasmids encoding green fluorescent protein
(GFP) fusion proteins by using liposomes (lipofectamine;
Invitrogen). 5 h later, the transfection medium was replaced
by fresh medium or a viral inoculum at a multiplicity of
infection (moi) of 10. At 15 h post-transfection or post-
infection, cells were rinsed twice with phosphate-buffered
saline (PBS) for subsequent use in fluorescence-activated
cell sorter (FACS) analysis or confocal microscopy.
Cloning, sequencing and computer analysis of DNA and
protein sequences
DNA and protein sequences were analyzed using DNA
Strider 1.3 software (Marck, 1988), the BLAST program
(GenBank) and the Web site http://www.poxvirus.org.
Sequence alignments of scrapins were performed using
Clustal software.
Construction of GFP fusions
Fusion plasmids were obtained by subcloning specific
MV-LAP fragments into the pEGFP plasmid vector (BD
Biosciences Clontech), which contains a jellyfish GFP gene
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CMV promoter. MV-LAP DNA comprising nucleotides (nt)
1–621, DCR (nt 1–459), N-MVLAP (nt 1–285), DC4HC3
(nt 1–69 fused to nt 204–621), C-MVLAP (nt 285–621)
and DC4HC3DCR (nt 1–69 fused to nt 204–459 then to nt
540–621) were generated by PCR using purified MV DNA
as a template (Petit et al., 1996). PCR products were
digested with the restriction enzymes BglII and PstI and
cloned into the corresponding sites of pEGFP, yielding
fusions containing GFP at the N-terminus of the chimeric
polypeptide (see Table 1). The integrity of MV fragments
was assessed by sequencing.
pmyxGFP-MVLAP was derived from pEGFP-MVLAP
after amplification of the promoter region of the M153R gene
using primers 5V-AseI-pmyx (5V-CAGATTAATACGGCC-
TACGGATGTTCTAACG-3V) and 3V-Nhe I-pmyx (5V-
GACGCTAGCGTTTACACAACCTATTTACTTTAATT-
GAC-3V). The resulting fragment was inserted between the
AseI and NheI sites in pEGFP-MVLAP, thus replacing the
CMV promoter of pEGFP-MVLAP by the natural promoter
of MV-LAP.
Confocal microscopy observations
A375 cells were plated onto LabTek multichamber slide
flasks (Falcon). At 15 h post-transfection and/or post-
infection, cells were rinsed twice in PBS, fixed for 90 min at
room temperature with 4% paraformaldehyde in PBS and
permeabilized with 0.1% Triton X-100 for 30 min at room
temperature. Cells were then incubated with mouse anti-
human EEA1 antibodies (1/100; BD Biosciences Pharmin-
gen), rabbit anti-calnexin antibodies (1/100; StressGen) or
mouse anti-human Lamp1 antibodies (1/100; BD Bioscien-
ces Pharmingen) in 0.05% Tween in PBS for 1 h at 37 -C,
rinsed three times in PBS-Tween and incubated in biotiny-
lated goat anti-rabbit antibodies (1/500; Sigma) or biotiny-
lated goat anti-mouse antibodies (1/200, Vector) for 1 h at
37 -C. Cy3-conjugated streptavidin (Jackson ImmunoRe-
search) was added at a dilution of 1/10,000 in PBS and
incubated for 30 min at 4 -C. After three PBS washes, the
samples were mounted with PBS–glycerol (1:1) and
observed with a confocal LSM Olympus microscope fitted
with a 60 Olympus objective.
Construction of MVA-gfpMVLAP recombinant
The pEGFP-MVLAP plasmid containing a jellyfish gfp
gene fused at the N-terminus of the MV-LAP (Guerin et
al., 2002) was used as a template to generate a PCR
product comprising the chimeric GFP/LAP fusion gene.
The primers were GFP-fusLAP-sense-BamHI (5V-GGGC-
GGATCCATGGTGAGCAAGGGCGAG-3V) paired with
MV-LAP-antisense-PmeI (5V-GGGCGTTTAAACCTAA-
GCGGGTGACTCCACGAC-3V). The resulting PCR frag-
ment was digested with the restriction enzymes BamHI and
PmeI and cloned between the corresponding unique sitesof pIIIDHR-P7.5 to generate the MVA transfer vector
plasmid pIIIDHR-P7.5-GFP/LAP. The integrity of the
amplified GFP/LAP fusion fragment was assessed by
sequencing. Recombinant MVA expressing the MV-LAP
gene fused to the gfp gene under control of the vaccinia virus-
specific early/late P7.5 promoter, which was termed MVA-
GFP-MVLAP, was constructed as described recently (Staib
et al., 2000, 2004). Recombinant virus was propagated and
titered following standard methodology. To generate stock
preparations, virus was routinely purified by ultracentrifuga-
tion through sucrose and reconstituted in 10 mM Tris pH 7.4,
120 mM NaCl saline buffer (Staib et al., 2000, 2004).
Flow cytometry analysis of transfected and infected cells
Cells were washed in PBS/BSA (1%) on 96-well plates
and pre-incubated for 30 min with purified rat anti-mouse
CD16/CD32 (FcgIII/II receptor) monoclonal antibody (1/
100; 2.4G2 (FcBlock); BD Biosciences Pharmingen). They
were then washed, stained with mouse anti-human HLA
A2.1 hybridoma supernatant IgG2b (BB7.2 (ATCC HB-
82)), diluted 1:5 in PBS/BSA (1%) for 45 min, washed
again and stained with F(abV)2 goat anti-mouse IgG-PE
antibody (1/500, Jackson ImmunoResearch) for 30 min.
They were then washed again and analyzed using a Becton
Dickinson FACScalibur. To determine viability of the cells,
propidium iodide (BD Biosciences Pharmingen) was added
to cells (50 Ag/ml). Graphs were plotted using CellQuestPro
Software.Note added in proof
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